文献速递鼻科

布地奈德与生理盐水鼻腔冲洗治疗过敏性鼻炎:随机安慰剂对照试验

Budesonide vs Saline Nasal Irrigation in Allergic Rhinitis: A Randomized Placebo-Controlled Trial.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-05-12

两组SNOT-22、VAS及改良Lund-Kennedy评分均改善(P < .001),布地奈德组在SNOT-22(P = .012)和VAS(P = .007)上优于盐水组,但临床反应差异不显著(P = .268)。

要点

  • 布地奈德鼻腔冲洗在过敏性鼻炎中可改善主观症状评分
  • 布地奈德组SNOT-22和VAS改善优于单纯盐水冲洗组
  • 两组改良Lund-Kennedy临床评分差异无统计学意义

核心结论

  • 盐水鼻腔冲洗治疗过敏性鼻炎有证据支持,加用布地奈德可进一步改善主观症状。
  • 布地奈德鼻腔冲洗可能是过敏性鼻炎可行的治疗选择。

研究设计与样本

  • 前瞻性、单中心、双盲、随机安慰剂对照试验。
  • 干预分别为缓冲高渗盐水鼻腔冲洗加安慰剂respule或加布地奈德respule。
  • 基线及4周时使用SNOT-22问卷和VAS进行主观评估,使用改良Lund-Kennedy评分进行临床评估。

主要发现

  • 两组平均SNOT-22、VAS和改良Lund-Kennedy评分均改善(P < .001)。
  • 布地奈德冲洗组SNOT-22评分改善显著优于盐水冲洗组(P = .012)。
  • 布地奈德冲洗组VAS评分改善显著优于盐水冲洗组(P = .007)。
  • 两组临床反应差异不显著(P = .268)。

关键数值与推荐

  • SNOT-22组间比较P = .012。
  • VAS组间比较P = .007。
  • 改良Lund-Kennedy评分组间比较P = .268。
  • 两组内SNOT-22、VAS和改良Lund-Kennedy评分改善P < .001。

临床怎么用

  • 对过敏性鼻炎患者可考虑使用缓冲高渗盐水鼻腔冲洗。
  • 在盐水冲洗中加入布地奈德可能进一步改善主观症状评分。
  • 临床决策需结合主观评分与客观临床评估综合判断。

局限性

  • 单中心研究。
  • 评估时间为4周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Budesonide nasal irrigation is currently widely used in the treatment of chronic sinusitis typically following endoscopic sinus surgery to improve inflammatory control. Its application in treatment of allergic rhinitis has not been previously studied. This study assesses the subjective and clinical response to budesonide buffered hypertonic saline nasal irrigation and hypertonic saline nasal irrigation in patients with allergic rhinitis. STUDY DESIGN: This is a prospective, single-center, double-blind, randomized placebo-controlled trial. SETTING: Tertiary care hospital. SUBJECTS AND METHODS: Fifty-two patients diagnosed with allergic rhinitis were randomized into 2 groups to receive either buffered hypertonic saline nasal irrigation with a placebo respule or buffered hypertonic saline nasal irrigation with a budesonide respule. Patients were assessed at baseline and 4 weeks subjectively using the Sino-Nasal Outcome Test-22 (SNOT-22) questionnaire and visual analog scale (VAS). Clinical assessment was done using the modified Lund-Kennedy score. RESULTS: The average SNOT-22, VAS, and modified Lund-Kennedy scores improved in both groups (P < .001). The budesonide irrigation group was found to have significantly better improvement than the saline nasal irrigation group with the SNOT-22 scores (P = .012) and VAS scores (P = .007). However, the difference in the clinical response between the 2 groups was not significant (P = .268). CONCLUSION: This study adds evidence to the use of saline nasal irrigation in allergic rhinitis but also demonstrates efficacy of the addition of budesonide to irrigations. Budesonide nasal irrigation thus appears to be a viable treatment option for allergic rhinitis.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Periasamy N, Pujary K, Bhandarkar AM, et al. Budesonide vs Saline Nasal Irrigation in Allergic Rhinitis: A Randomized Placebo-Controlled Trial. Otolaryngol Head Neck Surg. 2020. PMID: 32393099. doi:10.1177/0194599820919363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。